Global Animal Vaccines Market Research Report 2021

Publisher Name :
Date: 20-Jan-2021
No. of pages: 120
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Attenuated Vaccines

- Inactivated Vaccines

- Subunit Vaccines

- Toxoid Vaccines

- Conjugate Vaccines

- Recombinant Vaccines

- DNA Vaccines

Segment by Application

- Companion Animals

- Cattle

- Pigs

- Poultry

- Sheep

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Zoetis

- Merck Animal Health

- Boehringer Ingelheim

- Elanco

- Virbac

- Vetoquinol

- Phibro Animal Health

- Hester Biosciences

- Hipra

- IDT Biologika

- Biogenesis Bago

- Tianjin Ringpu

- China Animal Husbandry

Global Animal Vaccines Market Research Report 2021

Table of Contents
1 Animal Vaccines Market Overview
1.1 Product Overview and Scope of Animal Vaccines
1.2 Animal Vaccines Segment by Type
1.2.1 Global Animal Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Subunit Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Conjugate Vaccines
1.2.7 Recombinant Vaccines
1.2.8 DNA Vaccines
1.3 Animal Vaccines Segment by Application
1.3.1 Animal Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Companion Animals
1.3.3 Cattle
1.3.4 Pigs
1.3.5 Poultry
1.3.6 Sheep
1.4 Global Animal Vaccines Market Size Estimates and Forecasts
1.4.1 Global Animal Vaccines Revenue 2016-2027
1.4.2 Global Animal Vaccines Sales 2016-2027
1.4.3 Animal Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Animal Vaccines Market Competition by Manufacturers
2.1 Global Animal Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Animal Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Animal Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Animal Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Animal Vaccines Market Competitive Situation and Trends
2.5.1 Animal Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Animal Vaccines Players Market Share by Revenue
2.5.3 Global Animal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Vaccines Retrospective Market Scenario by Region
3.1 Global Animal Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Animal Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Animal Vaccines Market Facts & Figures by Country
3.3.1 North America Animal Vaccines Sales by Country
3.3.2 North America Animal Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Animal Vaccines Market Facts & Figures by Country
3.4.1 Europe Animal Vaccines Sales by Country
3.4.2 Europe Animal Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Animal Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Animal Vaccines Sales by Region
3.5.2 Asia Pacific Animal Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Animal Vaccines Market Facts & Figures by Country
3.6.1 Latin America Animal Vaccines Sales by Country
3.6.2 Latin America Animal Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Animal Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Animal Vaccines Sales by Country
3.7.2 Middle East and Africa Animal Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Animal Vaccines Historic Market Analysis by Type
4.1 Global Animal Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Animal Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Animal Vaccines Price by Type (2016-2021)
5 Global Animal Vaccines Historic Market Analysis by Application
5.1 Global Animal Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Animal Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Animal Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Zoetis Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Corporation Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Animal Health Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Boehringer Ingelheim Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Elanco Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Virbac Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Vetoquinol Product Portfolio
6.6.5 Vetoquinol Recent Developments/Updates
6.7 Phibro Animal Health
6.6.1 Phibro Animal Health Corporation Information
6.6.2 Phibro Animal Health Description and Business Overview
6.6.3 Phibro Animal Health Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Phibro Animal Health Product Portfolio
6.7.5 Phibro Animal Health Recent Developments/Updates
6.8 Hester Biosciences
6.8.1 Hester Biosciences Corporation Information
6.8.2 Hester Biosciences Description and Business Overview
6.8.3 Hester Biosciences Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hester Biosciences Product Portfolio
6.8.5 Hester Biosciences Recent Developments/Updates
6.9 Hipra
6.9.1 Hipra Corporation Information
6.9.2 Hipra Description and Business Overview
6.9.3 Hipra Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hipra Product Portfolio
6.9.5 Hipra Recent Developments/Updates
6.10 IDT Biologika
6.10.1 IDT Biologika Corporation Information
6.10.2 IDT Biologika Description and Business Overview
6.10.3 IDT Biologika Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 IDT Biologika Product Portfolio
6.10.5 IDT Biologika Recent Developments/Updates
6.11 Biogenesis Bago
6.11.1 Biogenesis Bago Corporation Information
6.11.2 Biogenesis Bago Animal Vaccines Description and Business Overview
6.11.3 Biogenesis Bago Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Biogenesis Bago Product Portfolio
6.11.5 Biogenesis Bago Recent Developments/Updates
6.12 Tianjin Ringpu
6.12.1 Tianjin Ringpu Corporation Information
6.12.2 Tianjin Ringpu Animal Vaccines Description and Business Overview
6.12.3 Tianjin Ringpu Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Tianjin Ringpu Product Portfolio
6.12.5 Tianjin Ringpu Recent Developments/Updates
6.13 China Animal Husbandry
6.13.1 China Animal Husbandry Corporation Information
6.13.2 China Animal Husbandry Animal Vaccines Description and Business Overview
6.13.3 China Animal Husbandry Animal Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 China Animal Husbandry Product Portfolio
6.13.5 China Animal Husbandry Recent Developments/Updates
7 Animal Vaccines Manufacturing Cost Analysis
7.1 Animal Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Animal Vaccines
7.4 Animal Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Animal Vaccines Distributors List
8.3 Animal Vaccines Customers
9 Animal Vaccines Market Dynamics
9.1 Animal Vaccines Industry Trends
9.2 Animal Vaccines Growth Drivers
9.3 Animal Vaccines Market Challenges
9.4 Animal Vaccines Market Restraints
10 Global Market Forecast
10.1 Animal Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Animal Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Animal Vaccines by Type (2022-2027)
10.2 Animal Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Animal Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Animal Vaccines by Application (2022-2027)
10.3 Animal Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Animal Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Animal Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Animal Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Animal Vaccines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Animal Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Animal Vaccines Covered in This Study
Table 5. Global Animal Vaccines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Animal Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Animal Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Animal Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Animal Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Animal Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Animal Vaccines Product Type
Table 12. Global Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Animal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Animal Vaccines Sales by Region (2016-2021) & (K Units)
Table 16. Global Animal Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Animal Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Animal Vaccines Sales by Country (2016-2021) & (K Units)
Table 19. North America Animal Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Animal Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Animal Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Animal Vaccines Sales by Country (2016-2021) & (K Units)
Table 23. Europe Animal Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Animal Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Animal Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Animal Vaccines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Animal Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Animal Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Animal Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Animal Vaccines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Animal Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Animal Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Animal Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Animal Vaccines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Animal Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Animal Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Animal Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Animal Vaccines Sales (K Units) by Type (2016-2021)
Table 39. Global Animal Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Animal Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Animal Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Animal Vaccines Price (USD/Unit) by Type (2016-2021)
Table 43. Global Animal Vaccines Sales (K Units) by Application (2016-2021)
Table 44. Global Animal Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Animal Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Animal Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Animal Vaccines Price (USD/Unit) by Application (2016-2021)
Table 48. Zoetis Corporation Information
Table 49. Zoetis Description and Business Overview
Table 50. Zoetis Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Zoetis Animal Vaccines Product
Table 52. Zoetis Recent Developments/Updates
Table 53. Merck Animal Health Corporation Information
Table 54. Merck Animal Health Description and Business Overview
Table 55. Merck Animal Health Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Merck Animal Health Animal Vaccines Product
Table 57. Merck Animal Health Recent Developments/Updates
Table 58. Boehringer Ingelheim Corporation Information
Table 59. Boehringer Ingelheim Description and Business Overview
Table 60. Boehringer Ingelheim Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Boehringer Ingelheim Animal Vaccines Product
Table 62. Boehringer Ingelheim Recent Developments/Updates
Table 63. Elanco Corporation Information
Table 64. Elanco Description and Business Overview
Table 65. Elanco Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Elanco Animal Vaccines Product
Table 67. Elanco Recent Developments/Updates
Table 68. Virbac Corporation Information
Table 69. Virbac Description and Business Overview
Table 70. Virbac Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Virbac Animal Vaccines Product
Table 72. Virbac Recent Developments/Updates
Table 73. Vetoquinol Corporation Information
Table 74. Vetoquinol Description and Business Overview
Table 75. Vetoquinol Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Vetoquinol Animal Vaccines Product
Table 77. Vetoquinol Recent Developments/Updates
Table 78. Phibro Animal Health Corporation Information
Table 79. Phibro Animal Health Description and Business Overview
Table 80. Phibro Animal Health Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Phibro Animal Health Animal Vaccines Product
Table 82. Phibro Animal Health Recent Developments/Updates
Table 83. Hester Biosciences Corporation Information
Table 84. Hester Biosciences Description and Business Overview
Table 85. Hester Biosciences Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Hester Biosciences Animal Vaccines Product
Table 87. Hester Biosciences Recent Developments/Updates
Table 88. Hipra Corporation Information
Table 89. Hipra Description and Business Overview
Table 90. Hipra Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Hipra Animal Vaccines Product
Table 92. Hipra Recent Developments/Updates
Table 93. IDT Biologika Corporation Information
Table 94. IDT Biologika Description and Business Overview
Table 95. IDT Biologika Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. IDT Biologika Animal Vaccines Product
Table 97. IDT Biologika Recent Developments/Updates
Table 98. Biogenesis Bago Corporation Information
Table 99. Biogenesis Bago Description and Business Overview
Table 100. Biogenesis Bago Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Biogenesis Bago Animal Vaccines Product
Table 102. Biogenesis Bago Recent Developments/Updates
Table 103. Tianjin Ringpu Corporation Information
Table 104. Tianjin Ringpu Description and Business Overview
Table 105. Tianjin Ringpu Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Tianjin Ringpu Animal Vaccines Product
Table 107. Tianjin Ringpu Recent Developments/Updates
Table 108. China Animal Husbandry Corporation Information
Table 109. China Animal Husbandry Description and Business Overview
Table 110. China Animal Husbandry Animal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. China Animal Husbandry Animal Vaccines Product
Table 112. China Animal Husbandry Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Animal Vaccines Distributors List
Table 116. Animal Vaccines Customers List
Table 117. Animal Vaccines Market Trends
Table 118. Animal Vaccines Growth Drivers
Table 119. Animal Vaccines Market Restraints
Table 120. Global Animal Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 121. Global Animal Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Animal Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Animal Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Animal Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 125. Global Animal Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Animal Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Animal Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Animal Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 129. Global Animal Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Animal Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Animal Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Vaccines
Figure 2. Global Animal Vaccines Market Share by Type in 2020 & 2027
Figure 3. Attenuated Vaccines Product Picture
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Toxoid Vaccines Product Picture
Figure 7. Conjugate Vaccines Product Picture
Figure 8. Recombinant Vaccines Product Picture
Figure 9. DNA Vaccines Product Picture
Figure 10. Global Animal Vaccines Market Share by Application in 2020 & 2027
Figure 11. Companion Animals
Figure 12. Cattle
Figure 13. Pigs
Figure 14. Poultry
Figure 15. Sheep
Figure 16. Global Animal Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Animal Vaccines Market Size 2016-2027 (US$ Million)
Figure 18. Global Animal Vaccines Sales 2016-2027 (K Units)
Figure 19. Global Animal Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Animal Vaccines Sales Share by Manufacturers in 2020
Figure 21. Global Animal Vaccines Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Animal Vaccines Players: Market Share by Revenue in 2020
Figure 23. Animal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Animal Vaccines Sales Market Share by Region (2016-2021)
Figure 25. Global Animal Vaccines Sales Market Share by Region in 2020
Figure 26. Global Animal Vaccines Revenue Market Share by Region (2016-2021)
Figure 27. Global Animal Vaccines Revenue Market Share by Region in 2020
Figure 28. U.S. Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Animal Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Animal Vaccines by Type (2016-2021)
Figure 53. Sales Market Share of Animal Vaccines by Application (2016-2021)
Figure 54. Sales Market Share of Animal Vaccines by Application in 2020
Figure 55. Revenue Share of Animal Vaccines by Application (2016-2021)
Figure 56. Revenue Share of Animal Vaccines by Application in 2020
Figure 57. Manufacturing Cost Structure of Animal Vaccines
Figure 58. Manufacturing Process Analysis of Animal Vaccines
Figure 59. Animal Vaccines Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs